FIELD: medicine.
SUBSTANCE: invention concerns chemical pharmaceutical industry and cytoprotection medication of 2-ethyl-6-methyl-3-oxypyridine succinate. Claimed medication of 2-ethyl-6-methyl-3-oxypyridine succinate, such as capsule, is distinguished from existing drugs by reduced content of starch, microcrystalline cellulose and polyvinylpyrrolidone and absence of talc.
EFFECT: improved biological accessibility of 2-ethyl-6-methyl-3-oxypyridine succinate, reduced amount of inert substances.
1 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL FORMULATION IN SOLID DOSAGE FORM AND METHOD FOR PREPARING IT | 2010 |
|
RU2445091C1 |
| PHARMACEUTIC COMBINATION OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE AND PYRIDOXINE, METHOD OF ITS OBTAINING AND METHOD OF TREATMENT | 2008 |
|
RU2405552C2 |
| DRUG SHOWING ANXIOLYTIC, ANTIALCOHOLIC AND CEREBROPROTECTIVE EFFECTS | 1999 |
|
RU2145855C1 |
| SYNERGETIC PREPARATION FOR TREATING CARDIOVASCULAR DISEASES, DIABETES MELLITUS AND HEPATOBILIARY DISEASES | 2012 |
|
RU2493841C1 |
| ANTIOXIDANT AND ANTIHYPOXIC AGENT OF 6-METHYL-2-ETHYL-3-HYDROHYPYRIDINE SUCCINATE | 2008 |
|
RU2398583C2 |
| PHARMACEUTICAL COMPOSITION WITH 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE FOR ORAL ADMINISTRATION AND METHOD FOR PREPARING IT | 2010 |
|
RU2444359C1 |
| AGENT FOR CORRECTION OF METABOLIC SYNDROME AND METHOD OF TREATMENT OF VASCULAR COMPLICATIONS INDUCED BY CARBOHYDRATE METABOLISM IMPAIRMENT | 2001 |
|
RU2185826C1 |
| SOLID INDIVIDUAL HIGH 2-ETHYL-6-METHYL-3-PYRIDIN-3-OLE HYDROCHLORIDE DOSAGE FORM AND METHOD FOR PREPARING IT | 2010 |
|
RU2448686C1 |
| COMPOSITION OF 3-OXY-6-METHYL-2-ETHYLPYRIDINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT IN TABLETTED FORM, METHOD FOR MAKING THEREOF, AND THERAPY | 2007 |
|
RU2384330C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING CONSEQUENCES OF CRANIOCEREBRAL INJURY AND METHOD FOR PRODUCTION THEREOF (EMBODIMENTS) | 2018 |
|
RU2693633C1 |
